Keytruda Approved in China for Esophageal Squamous Cell Carcinoma Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter Keytruda is now approved in China for three different types of cancer. Source: Devices & Diagnostics Letter You Might Also Like Sinopharm to Begin Phase 3 Trial of its COVID-19 Vaccine Candidate in Peru August 20, 2020 State Treasurers Accuse Gilead of Seeking ‘Unreasonable Profits’ From Remdesivir September 20, 2020 Norlase Gets CE Mark for Leaf Laser July 22, 2020